ESOMEPRAZOLE\NAPROXEN: 5,684 Adverse Event Reports & Safety Profile
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
5,684
Total FAERS Reports
1,083 (19.1%)
Deaths Reported
352
Hospitalizations
5,684
As Primary/Secondary Suspect
161
Life-Threatening
120
Disabilities
Active Ingredient: ESOMEPRAZOLE MAGNESIUM\NAPROXEN ·
First Report: 1976 · Latest Report: 20250513
What Are the Most Common ESOMEPRAZOLE\NAPROXEN Side Effects?
#1 Most Reported
Chronic kidney disease
2,714 reports (47.7%)
#2 Most Reported
Renal failure
2,374 reports (41.8%)
#3 Most Reported
Acute kidney injury
1,120 reports (19.7%)
All ESOMEPRAZOLE\NAPROXEN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Chronic kidney disease | 2,714 | 47.8% | 412 | 89 |
| Renal failure | 2,374 | 41.8% | 830 | 84 |
| Acute kidney injury | 1,120 | 19.7% | 234 | 78 |
| Death | 705 | 12.4% | 703 | 7 |
| Drug ineffective | 459 | 8.1% | 16 | 32 |
| Off label use | 440 | 7.7% | 18 | 43 |
| Nausea | 431 | 7.6% | 16 | 96 |
| End stage renal disease | 349 | 6.1% | 123 | 23 |
| Tubulointerstitial nephritis | 315 | 5.5% | 56 | 19 |
| Hyperhidrosis | 308 | 5.4% | 0 | 5 |
| Pain | 283 | 5.0% | 18 | 101 |
| Nightmare | 247 | 4.4% | 0 | 0 |
| Sedation | 244 | 4.3% | 0 | 0 |
| Rheumatoid arthritis | 235 | 4.1% | 18 | 95 |
| Fatigue | 200 | 3.5% | 18 | 95 |
| Arthralgia | 195 | 3.4% | 14 | 28 |
| Product use in unapproved indication | 186 | 3.3% | 2 | 4 |
| Nephrolithiasis | 174 | 3.1% | 0 | 0 |
| Cough | 172 | 3.0% | 0 | 69 |
| Dyspnoea | 165 | 2.9% | 17 | 33 |
Who Reports ESOMEPRAZOLE\NAPROXEN Side Effects? Age & Gender Data
Gender: 48.7% female, 51.3% male. Average age: 55.7 years. Most reports from: US. View detailed demographics →
Is ESOMEPRAZOLE\NAPROXEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 2 | 0 | 1 |
| 2001 | 7 | 3 | 0 |
| 2002 | 2 | 0 | 1 |
| 2003 | 13 | 6 | 2 |
| 2004 | 12 | 4 | 4 |
| 2005 | 16 | 8 | 2 |
| 2006 | 23 | 13 | 0 |
| 2007 | 29 | 7 | 4 |
| 2008 | 34 | 9 | 11 |
| 2009 | 32 | 10 | 5 |
| 2010 | 35 | 8 | 1 |
| 2011 | 98 | 39 | 16 |
| 2012 | 76 | 13 | 9 |
| 2013 | 85 | 9 | 10 |
| 2014 | 111 | 7 | 18 |
| 2015 | 172 | 10 | 30 |
| 2016 | 147 | 8 | 26 |
| 2017 | 77 | 4 | 14 |
| 2018 | 75 | 0 | 10 |
| 2019 | 55 | 1 | 8 |
| 2020 | 23 | 0 | 8 |
| 2021 | 9 | 3 | 2 |
| 2022 | 4 | 0 | 2 |
| 2023 | 12 | 1 | 7 |
| 2024 | 2 | 0 | 1 |
| 2025 | 2 | 0 | 2 |
What Is ESOMEPRAZOLE\NAPROXEN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 3,129 |
| Arthritis | 77 |
| Pain | 74 |
| Arthralgia | 63 |
| Osteoarthritis | 63 |
| Rheumatoid arthritis | 46 |
| Gastrooesophageal reflux disease | 36 |
| Back pain | 34 |
| Inflammation | 27 |
| Pain in extremity | 18 |
ESOMEPRAZOLE\NAPROXEN vs Alternatives: Which Is Safer?
ESOMEPRAZOLE\NAPROXEN vs ESTAZOLAM
ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL
ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL CYPIONATE
ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL\LEVONORGESTREL
ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL\NORETHINDRONE
ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL\NORETHINDRONE\RELUGOLIX
ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL\PROGESTERONE
ESOMEPRAZOLE\NAPROXEN vs ESTRAMUSTINE
ESOMEPRAZOLE\NAPROXEN vs ESTRING
ESOMEPRAZOLE\NAPROXEN vs ESTRIOL
Official FDA Label for ESOMEPRAZOLE\NAPROXEN
Official prescribing information from the FDA-approved drug label.